Schizophrenia Trial, Recruiting NCT06224530 Sponsor: King's College London Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT06224530
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

This trial has two groups of participants — people considered "at risk" of psychosis (CHR-P group), and healthy volunteers (HC group).

For the "at-risk" group:

  • You are between 18 and 40 years old
  • You are able to understand the study and agree to take part
  • You have been assessed and identified as being at higher risk of developing psychosis, based on a specific clinical assessment tool (called the CAARMS)
  • Your assessment shows you experience certain unusual thoughts or beliefs at a mild to moderate level (confirm with trial site)

For the healthy volunteer group:

  • You are between 18 and 40 years old
  • You are able to understand the study and agree to take part

Who may not be able to join:

For the "at-risk" group:

  • You have previously had a full episode of psychosis
  • You are currently taking certain medications that strongly affect brain chemistry, such as benzodiazepines, anti-seizure drugs, mood stabilisers, sleeping tablets (zopiclone or zolpidem), ketamine, opiates, atomoxetine, or memantine
  • You are currently or recently taking any antipsychotic medication
  • You have been diagnosed with a neurological condition, including epilepsy
  • You are currently pregnant or breastfeeding
  • You have severe kidney problems
  • You have a known allergy to a medication called levetiracetam
  • You have any reason you cannot safely have an MRI scan
  • Your IQ is below 70, as measured by a specific test (WAIS-III)
  • You are acutely unwell to the point where you cannot consent to taking part

For the healthy volunteer group:

  • You have a personal history of any mental health condition
  • You have a parent, sibling, or child who has been diagnosed with a psychotic disorder
  • You have been diagnosed with a neurological condition, including epilepsy
  • You are currently pregnant, breastfeeding, or trying to conceive
  • You are currently taking certain medications that strongly affect brain chemistry, such as benzodiazepines, anti-seizure drugs, mood stabilisers, sleeping tablets (zopiclone or zolpidem), ketamine, opiates, atomoxetine, or memantine
  • You are currently or recently taking any antipsychotic medication
  • You have any reason you cannot safely have an MRI scan
  • Your IQ is below 70, as measured by a specific test (WAIS-III)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 July 2024
Est. completion
1 February 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Magnetic resonance Imaging (MRI) measure of rCBF using arterial spin labelling (ASL) in the hippocampus.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov